VNS Market
Jul 02, 2021
Vagus Nerve Stimulators Market Outlook
Vagus nerve stimulators (VNS) is a neuromodulation therapy approved by the United States Food and Drug Administration (FDA) as a palliative treatment for patients with both epilepsy and depressions. Other non-FDA-approved uses of VNS have been studied and explored in various small open-labeled studies which include...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
